Understanding the risks associated with resource allocation decisions in health: An illustration of the importance of portfolio theory

Health, Risk and Society

Volumn 6, Issue 3, 2004, Pages 257-275

  Bridges, John F P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Economic evaluation; Portfolio; Risk; Uncertainty

Indexed keywords

ANALYSIS OF VARIANCE; ARTICLE; COST EFFECTIVENESS ANALYSIS; COVARIANCE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE FINANCING; HEALTH CARE PLANNING; HEALTH ECONOMICS; HEALTH HAZARD; HEALTH PROMOTION; HUMAN; MEDICAL DECISION MAKING; MEDICAL LITERATURE; OUTCOMES RESEARCH; PROCESS OPTIMIZATION; RESOURCE ALLOCATION; RISK ASSESSMENT; STATISTICAL ANALYSIS; THEORETICAL STUDY;

EID: 7244234361     PISSN: 13698575     EISSN: None     Source Type: Journal    
DOI: 10.1080/1369857042000275669     Document Type: Article

References (70)

1. Alaszewski, A., Alaszewski, H., Ayer, S. and Manthorpe, J. (2000) Managing Risk in Community Practice: Nursing, Risk and Decision Making (London, Harcourt Publishers).
2. Allardice, G., McMenamin, J., Parpia, T., Gibbs, J., McSharry, C. and Whitelaw, J. (1998) The recent impact of antiretroviral therapy on CD4 counts, AIDS and death in HIV-infected persons: routine HIV surveillance in Scotland, International Journal of STD and AIDS 9, pp. 561-566.
3. Amendinger, J., Becherer, D., and Schweizer, M. (2003) A monetary value for initial information in portfolio optimisation, Finance and Stochastics, 7, pp. 29-46.
4. Aronow, W., Ahn, C. and Kronzon, I. (2001) Effect of beta blockers alone, of angiotensin-converting enzyme inhibitors alone, and of beta blockers plus angiotensin-converting enzyme inhibitors on new coronary events and on congestive heart failure in older persons with healed myocardial infarcts and asymptomatic left ventricular systolic dysfunction, Am J Cardiol, 88, pp. 1298-1300.
5. Birch, S. and Donaldson, C. (1987) Cost-benefit analysis: dealing with the problems of indivisible projects and fixed budgets, Health Policy, 7, pp. 61-72.
6. Birch, S. (2002) Making the problem fit the solution: Evidence-based decision-making and 'dolly' economics, in: L Donaldson, C.M. Mugford and L. Vale (Eds) Evidence-Based Health Economics: From Effectiveness to Efficiency in Systematic Review, pp. 133-147 (London, BMJ Books).
7. Birch, S. and Donaldson, C. (2003) Valuing the benefits and costs of health care programmes: Where's the extra in extra wefarism? Social Science and Medicine, 56, pp. 1121-1133.
8. Birch, S. and Gafni, A. (1992) Cost effectiveness/utility analysis. Do current decision rules lead us to where we want to be? Journal of Health Economics, 11, pp. 279-296.
9. Black, F. and Scholes, M. (1973) The pricing of options and corporate liabilities, Journal of Political Economy, 81, pp. 637-659.
10. Black, N. (1996) Why we need observational studies to evaluate the effectiveness of health care, BMJ, 12, pp. 1215-1218.
11. Brealey, R. and Myers. S. (1991) Principles of Corporate Finance, International Edition, 4th edn (New York: McGraw Hill).
12. Bridges, J. (2003a) 'Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics', Applied Health Economics and Health Policy, 2, pp. 213-224.
13. Bridges, J. (2003b) 'Clopidogrel and percutaneous coronary interventions' Letter to the Editor, JAMA, 289, pp. 1925-1926.
14. Bridges, J., Stewart, M., King, M., and van Gool, K. (2002) Adapting portfolio theory for investment in health with a multiplicative extension for treatment synergies, European Journal of Health Economics, 3, pp. 47-53.
15. Bridges, J. and Terris, D. (2004) 'Portfolio evaluation of health programs: A reply to Sendi et al', Social Science and Medicine 58, pp. 1849-1851.
16. Brennan, M. (1998) The role of learning in dynamic portfolio decisions, European Finance Review, 1, pp. 295-306.
17. Brewly, T.F. (2002) Knightian decision theory. Part 1. Decisions in Economics and Finance, 25, pp. 79-110.
18. Briggs, A.H., Wonderling, D.E. and Mooney, C.Z. (1997) Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation, Health Economics, 6, pp. 327-340.
19. Carnett, W. (1999) Clinical practice guidelines: A tool to improve care, Qual Manag Health Care, 8, pp. 13-21.
20. Chaudhary, M. and Stearns, S. (1996) Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized clinical trial, Statistics in Medicine, 15, pp. 1447-1458.
21. Chen, Z. and Epstein, L. (2002) Ambiguity, risk, and asset returns in continuous time, Econometrica, 703 pp. 1403-1443.
22. Claxton, K. (1999) Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticals, Health Economics, 8, pp. 269-274.
23. Claxton, K., Lacey, L.F. and Walker, S.G. (2000) Selecting treatments: A decision theoretic approach, Journal of the Royal Statistical Society, Series A, 163(2), pp. 211-225.
24. Cortina, J. and Nouri, H. (1999) Effect Size for ANOVA Designs, Statistical Series #129 (Thousand Oaks, CA, SAGE Publications).
25. Donaldson, C. and Shackley, P. (1997) Does 'process utility' exist? A case study of willingness to pay for laparoscopic cholesystectomy, Social Science and Medicine, 44, pp. 699-707.
26. Drummond, M., and O'Brien, B. (1993) Clinical importance, statistical significance and the assessment of economic and quality of life outcomes, Health Economics, 2, pp. 336-346.
27. Elixhauser, A., Halpern, M., Schmier, J. and Luce, B.R. (1998) Healthcare CBA and CEA from 1991-1996: An Updated Bibliography, Medical Care, 36, pp. MS4-MS55.
28. Fenwick, E., Claxton, K. and Sculpher, M. (2001) Representing uncertainty: the role of cost-effectiveness acceptability curves, Health Economics, 10, pp. 779-787.
29. Galligan, D., Ramberg, C., Curtis, C., Fergurson, J. and Fetrow, J. (1991) Application of portfolio theory in decision tree analysis, Journal of Dairy Science, 74(7), pp. 2138-2144.
30. Gerrity, M.S., Devellis, R.F. and Earp, J.A. (1990) Physicians' reactions to uncertainty in patient care: A new measure and new insights, Medical Care, 28, pp. 724-736.
31. Gollier, C. (2001) The Economics of Risk and Time, (Cambridge, MA, MIT Press).
32. Graff Zivin, J. (2001) Cost-effectiveness analysis with risk aversion, Health Economics, 10, pp. 499-508.
33. Graff Zivin, J. and Bridges, J. (2002) Addressing risk preferences in cost-effectiveness analyses, Applied Health Economics and Health Policy, 1, pp. 135-139.
34. Gurfinkel, E., Manos, E., Mejail, R., Cerda, M., Duronto, E., Garcia, C., Daroca. A.M., and Mautner, B. (1995) Low molecular weight aspirin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia, Journal of the American College of Cardiologists, 26, pp. 313-318.
35. Hammer, S.M., Vaida, F., Bennett, K.K., Sheiner, L., Eron, J.J., Wheat, L.J., Mitsuyasu, R.T., Gulick, R.M., Valentine, F.T., Aberg, J.A., Rogers, M.D., Karol, C.N., Saah, A.J., Lewis, R.H., Bessen, L.J., Brosgart, C., DeGruttola, V., Mellors, J.W., AIDS Clinical Trials Group 398 Study Team. (2002) Dual vs single protease inhibito therapy following antiretroviral treatment failure: A randomised trial, JAMA, 288, pp. 169-180.
36. Hawe, P. and Shiell, A. (1995) Preserving innovation under increasing accountability pressures: The health promotion investment portfolio approach, Health Promotion Journal of Australia, 5, pp. 4-9.
37. Heckman, J. (1979) Sample selection bias as a specification error, Econometrica, 47, pp. 153-162.
38. Heckman, J. and Smith, J. (1995) Assessing the case for randomized social experiments, The Journal of Economic Perspectives 9, pp. 85-110.
39. Herrick, A.B., Stone, W.J. and Mettler, M.M. (1997) Stages of change, decisional balance, and self-efficacy across four health behaviors in a worksite environment, American Journal of Health Promotion, 12, pp. 49-56.
40. Hewson, M., Kindy, P., van Kirk, J., Gennis, V. and Day, R. (1996) Strategies for managing uncertainty and complexity, Journal of General Internal Medicine, 11, pp. 481-485.
41. Hoffmann, C. and Graf von der Schulenberg, J.M. (2000) The influence of economic evaluation studies on decision making: A European study, Health Policy, 52, pp. 179-192.
42. Knight, F.H. (1921) Risk, Uncertainty and Profit (Boston, Houghton Mifflin).
43. Markowitz, H. (1952) Portfolio selection, Journal of Finance, 7, pp. 77-91.
44. McPherson, K., Wennberg, J., Hovind, O. and Clifford, P. (1982) Small area variations in the use of common surgical procedures: An international comparison of New England, England and Norway, New England Journal of Medicine, 307, pp. 1310-1314.
45. Mennemeyer, S.T. (1997) Can econometrics rescue epidemiology? Annals of Epidemiology, 7, pp. 249-250.
46. Merril, S. and McGeary, M. (1999) Who's balancing the federal research portfolio and how? Science, 285, pp. 1679-1680.
47. Merton, R.C. (1973) Theory of rational option pricing, Bell Journal of Economics and Management Science, 4, pp. 141-183.
48. Miller, W., Crabbtree, B., McDaniel, R. and Stange, K. (1998) Understanding change in primary care practice using complexity theory, The Journal of Family Practice, 46, pp. 369-376.
49. Miller, W., McDaniel, R., Crabbtree, B. and Stange, K. (2001) Practice Jazz: Understanding variation in family practice medicine using complexity science, The Journal of Family Practice, 50, pp. 872-878.
50. Mood, A.M., Graybill, F.A. and Boes, D.C. (1974) Introduction to the Theory of Statistics (New York: McGraw-Hill).
51. Mooney, G. and Lange, M. (1993) Anti-natal screening: What contributes to benefit? Social Science and Medicine, 37, pp. 873-878.
52. Mirrlees, J.A. (1999) The theory of moral hazard and unobservable behaviour: Part 1, Review of Economic Studies, 66, pp. 3-21.
53. Murray, M., Harris, L., Overhage, J., Zhou, X., Eckert, G., Smith, F., Buchanan, N.N., Wolinsky, F.D., McDonald, C.J. and Tierney, W.M. (2004) Failure of computerized treatment suggestions to improve health outcomes of outpatients with uncomplicated hypertension: results of a randomized controlled trial, Pharmacotherapy, 24, pp. 324-337.
54. Newhouse, J.P. and McClellan, M. (1998) Econometrics in outcomes research: The use of instrumental variables, Annual Review of Public Health, 19, pp. 17-34.
55. O'Brien, B. and Sculpher, M. (2000) Building uncertainty into cost-effectiveness rankings: Portfolio risk-return trade-offs and implications for decision rules, Medical Care, 38, pp. 460-468.
56. O'Brien, B., Drummond, M., Labelle, R. and Willan, A. (1994) In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care, Medical Care, 32, pp. 150-163.
57. Palmer, S., and Smith, P.C. (2000) Incorporating option values into the economic evaluation of health care technologies, Journal of Health Economics, 19, pp. 755-766.
58. Phillips, S., Burstin, H., Dillard, C. and Clancy, C. (2004) AHRQs bioterrorism research portfolio: Real linkages in real time, Health Services Research, 39, pp. xi-xv.
59. Ross, S.A. (1976) Arbitrage theory of capital asset pricing, Journal of Economic Theory, 13, pp. 341-360.
60. Simmons, M. (2003) Complexity theory in the management of communicable disease, The Journal of Hospital Infection, 54, pp. 87-92.
61. Sendi, P., Al, M.J., Gafni, A. and Birch, S. (2003) Optimizing a portfolio of health care programmes in the presence of uncertainty and constrained resources, Social Science & Medicine, 57, pp. 2207-2215.
62. Sendi, P., Gafni, A. and Birch, S. (2002) Opportunity costs and uncertainty in the economic evaluation of health care interventions, Health Economics, 11, pp. 23-31.
63. Sharpe, W. (1964) Capital asset prices - a theory of market equilibrium under conditions of risk, Journal of Finance, 19, pp. 425-442.
64. Steinhubl, S.R., Berger, P.B., Tift Mann, J., Fry, E.T.A., Deglago, A., Wilmer, C., et al. (2002) Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomised controlled trial, JAMA, 288, pp. 2411-2420.
65. Steinhubl, S., Berger, P.B., Mann, J., Fry, E., Delago, A., Wilmer, C. and Topol, E. (2003) Clopidogrel and percutaneous coronary interventions - reply, JAMA, 289, pp. 1926-1927.
66. Stinnett, A.A. and Paltiel, A.D. (1996) Mathematical programmeming for the efficient allocation of health care resources, Journals of Health Economics, 15, pp. 641-653.
67. Viscusi, W.K. and Chesson, H. (1999) Hopes and fears: The conflicting effects of risk ambiguity, Theory and Decision, 47, pp. 153-178.
68. Wakker, P. and Klaassen, M. (1995) Confidence intervals for cost/effectiveness ratios, Health Economics, 4, pp. 373-381.
69. Williams, A. (1987) Health economics: The cheerful face of a dismal science, in: A. Williams (Ed.) Health and Economics, pp. 1-11 (London, Macmillan).
70. Willson, T. and Holt, T. (2001) Complexity science: Complexity and clinical care, BMJ, 323, pp. 685-688.